Here we demonstrated that HSCARG plays an important role in the precise control of the cellular antiviral response by negatively regulating TRAF3 ubiquitination and IFN-β production, providing a potential target for the treatment of chronic inflammation and autoimmune disease. This evidence concerns the gene NMRAL1 and autoimmune disease.